ArticleAntioxidants (Basel, Switzerland)2026
Dietary (Poly)phenol Intake, Inflammatory Biomarkers, and Mild Cognitive Impairment in Italian Adults.
Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
backgroundDietary (poly)phenols have been proposed to protect against age-related cognitive decline through antioxidant, anti-inflammatory, and neuroprotective mechanisms. However, evidence specifically addressing mild cognitive impairment (MCI) remains limited. This study investigated the association between habitual dietary (poly)phenol intake, cognitive status, and circulating inflammatory biomarkers in older adults.
methodsIn this cross-sectional study, Italian adults aged ≥65 years attending a memory clinic underwent standardized neuropsychological assessment for MCI diagnosis. Habitual dietary intake was assessed using a validated food frequency questionnaire, and dietary (poly)phenol intake was estimated using the Phenol-Explorer database. Plasma transforming growth factor-β1 (TGF-β1) and tumor necrosis factor-α (TNF-α) concentrations were measured by ELISA. Logistic regression analyses were performed to evaluate associations between quartiles of (poly)phenol intake and MCI after adjustment for energy intake, age, sex, education, and smoking status.
resultsParticipants without MCI reported significantly higher intakes of total (poly)phenols and several subclasses, including flavonoids, anthocyanins, flavanones, flavones, hydroxycinnamic acids, and lignans. Higher intakes of flavanones, flavones, lignans, hesperetin, naringenin, lariciresinol, matairesinol, and pinoresinol were positively associated with cognitive performance. Individuals in the highest quartile of total (poly)phenol intake had substantially lower odds of MCI (adjusted OR = 0.08; 95% CI: 0.01-0.62), with similar inverse associations observed for flavonoids (OR = 0.16; 95% CI: 0.02-0.92), lignans (OR = 0.18; 95% CI: 0.04-0.89), flavones (OR = 0.18; 95% CI: 0.04-0.87), naringenin (OR = 0.19; 95% CI: 0.04-0.92), lariciresinol (OR = 0.18; 95% CI: 0.04-0.89), matairesinol (OR = 0.19; 95% CI: 0.04-0.93), and pinoresinol (OR = 0.16; 95% CI: 0.03-0.82), when compared to the lowest quartile. Total (poly)phenol intake was not associated with circulating inflammatory biomarkers, although biochanin A and caffeic acid were inversely associated with TNF-α concentrations.
conclusionsHigher habitual intake of selected dietary (poly)phenols, particularly flavonoids and lignans, was associated with a lower likelihood of MCI and better cognitive performance in older adults. However, the absence of consistent associations with inflammatory biomarkers does not support inference regarding an anti-inflammatory mechanism. Given the observational design, small sample size, and multiple statistical comparisons, these findings should be considered exploratory and hypothesis-generating. Prospective studies and randomized controlled trials are needed to confirm these associations and clarify the underlying biological pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.